1. Home
  2. ANNX vs BZH Comparison

ANNX vs BZH Comparison

Compare ANNX & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.47

Market Cap

730.4M

Sector

Health Care

ML Signal

HOLD

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$19.69

Market Cap

672.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
BZH
Founded
2011
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
730.4M
672.0M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
ANNX
BZH
Price
$5.47
$19.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$16.50
$32.00
AVG Volume (30 Days)
2.2M
349.2K
Earning Date
03-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
42.94
N/A
EPS
N/A
N/A
Revenue
N/A
$2,087,739,000.00
Revenue This Year
N/A
$4.36
Revenue Next Year
N/A
$10.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.29
$17.37
52 Week High
$7.18
$28.33

Technical Indicators

Market Signals
Indicator
ANNX
BZH
Relative Strength Index (RSI) 49.49 22.99
Support Level $4.77 N/A
Resistance Level $5.61 $24.10
Average True Range (ATR) 0.35 0.72
MACD 0.01 -0.41
Stochastic Oscillator 33.89 6.84

Price Performance

Historical Comparison
ANNX
BZH

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

Share on Social Networks: